Home > Healthcare > Pharmaceuticals > Vaccines > Microneedle Flu Vaccine Market
Microneedle Flu Vaccine Market Size
- Report ID: GMI9724
- Published Date: Jun 2024
- Report Format: PDF
Microneedle Flu Vaccine Market Size
Microneedle Flu Vaccine Market size was valued at USD 1.6 billion in 2023 and is anticipated to witness growth at a CAGR of 6.1% from 2024 and 2032. High growth can be attributed to the increasing prevalence of influenza and the need for more efficient and effective vaccination methods, that has spurred the market demand.
Additionally, the ability of microneedles to enhance vaccine immunogenicity and reduce the risk of needle-stick injuries among healthcare workers further boosts their adoption. Moreover, advancements in microneedle technology have improved the stability and efficacy of vaccines, further driving market growth. Further, the convenience of self-administration and reduced dependency on healthcare professionals make microneedle vaccines particularly attractive in both developed and developing regions, thereby propelling market expansion.
Microneedle flu vaccines are a novel delivery method for influenza vaccines that use microscopic needles to deliver the vaccine into the skin. These needles are typically less than a millimeter in length and are designed to painlessly penetrate the outer layers of the skin, where they dissolve and release the vaccine.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Microneedle Flu Vaccine Market Size in 2023: | USD 1.6 Billion |
| Forecast Period: | 2024 – 2032 |
| Forecast Period 2024 – 2032 CAGR: | 6.1% |
| 2024 – 2032 Value Projection: | USD 2.7 Billion |
| Historical Data for: | 2021 – 2023 |
| No. of Pages: | 148 |
| Tables, Charts & Figures: | 260 |
| Segments covered: | Product Type, Vaccine Type, Flu Type, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Microneedle Flu Vaccine Market Scope
